Back to search

United States· US:0220-1314_09bf01a1-7a37-609d-e063-6394a90a6408

Chininum sulphuricum

A quinine product containing quinine sulfate, registered in United States by Boiron. The same ATC class is registered in 9 of our 19 countries.

ATC P01BC01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedChininum sulphuricumATCP01BC01REGISTER NO.US:0220-1314_09bf01a1…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Quinine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BC01 (quinine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose

Quinine · ATC P01BC01

9 / 19 countries

  • Canada
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
QUININE SULFATE
Manufacturer
Boiron
Country
United States (US)
ATC code
P01BC01
ATC class
Quinine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0220131441
    200 [kp_C] in 1 TUBE (0220-1314-41)
  • ndc11
    0220-1314-41

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

496 interactions on record for quinine.

Graded by severity as the source publishes them — 102 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Quinine · interactions on record

496 records

  • 102 severe
  • 378 moderate
  • 16 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Sodium picosulfateA06AB08severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quinine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Cyprus · Quinine Sulphate Remedica
  • Germany · Chinin Axunio, Chinin Divapharma
  • Denmark · Chininsulfate Axunio
  • France · Quinine Renaudin
  • United Kingdom (Northern Ireland) · Quinine Bisulfate, Quinine Bisulfate Strides Pharma Uk
  • Ireland · Quinine Sulphate Teva
  • Italy · Chinina Cloridrato Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico Militare, Chinina Cloridrato Galenica Senese
  • Netherlands · A-Qs 200
  • Portugal · Quinina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/deb39723-dd4e-4b7a-8e8e-4193842ad9b5
GET /v1/drugs/deb39723-dd4e-4b7a-8e8e-4193842ad9b5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "200",
  "substance": "QUININE SULFATE",
  "productndc": "0220-1314",
  "dosage_form": "PELLET",
  "dea_schedule": null,
  "strength_unit": "[kp_C]/200[kp_C]",
  "application_number": null,
  "marketing_category": "UNAPPROVED HOMEOPATHIC"
}

See everything about quinine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.